RLMD
Relmada Therapeutics, Inc.Company with tickers: RLMD
CIK
1553643
CUSIP
75955J402
Shares Outstanding
104,890,223
Website
https://www.relmada.com
Investor Relations
https://www.relmada.com/for-investors
13F Activity (30d)
9 filings
8 filers
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Holders: 1
Total Value: $41,784,139
Total Shares: 6,508,433
Institutional Ownership Trend
29 quarters
Quarterly Activity
vs Apr 27, 2026
New
1
Increased
0
Decreased
0
Sold Out
1
Unchanged
0
Holder count:
0
Institutional value:
+8.0%
Shares held:
+18.2%
Top New Positions
vs Apr 27, 2026| Institution | Acquired | Value (USD) | Open |
|---|---|---|---|
| — Venrock Healthcare Capital Partners III, L.P. | 6,508,433 | $41,784,139 |
Top Sold-Out Positions
vs Apr 27, 2026| Institution | Previously Held | Last Value (USD) | Open |
|---|---|---|---|
| Mid Commodore Capital LP | 5,505,527 | $38,703,854 |
| Holder | Value (USD) | % of 13F | Shares | Type | Discretion | Filed | Open | |||
|---|---|---|---|---|---|---|---|---|---|---|
| — Venrock Healthcare Capital Partners III, L.P. | $41,784,139 | 100.00% | 6,508,433 | Shares | Sole | 2026-06-09 | ||||
| No holders match your search. | ||||||||||